Regenics vs He & She MD: Pricing, Support, and Medication Differences
The comparison Regenics vs He & She MD centers on pricing structure, clinician access, medication formats, and whether extras like peptide therapy or coaching are included. Early verdict: Regenics is a lower-cost cash-pay entry with a Sermorelin option and nurse-practitioner oversight, while He & She MD bundles coaching and 1:1 clinician messaging into six-month introductory plans.
View Regenics pricing and start options
Side-by-side snapshot: Regenics vs He & She MD
| Criteria | Regenics | He & She MD |
|---|---|---|
| Starting price | Semaglutide $139 first month; tirzepatide $189 first month | Semaglutide from $139/mo introductory; tirzepatide from $199/mo intro |
| Promotional term | Promotional pricing applies to the first month only; renewals higher | Six-month introductory rates that renew higher after six months |
| Clinician model | Licensed nurse practitioners review intake and oversee prescriptions | 1:1 clinician messaging and a named Chief Medical Officer supports care |
| Support and tools | Telehealth only; offers Sermorelin peptide therapy as an add-on | Coaching app with GLP-1 coaching and progress tracking included |
| Medication formats | Compounded semaglutide and tirzepatide | Semaglutide injection, oral semaglutide, or tirzepatide injection |
| Pharmacy and regulatory note | Compounded by U.S. licensed pharmacies; compounded products not FDA-approved or reviewed for safety, effectiveness or quality | Produced in USP-compliant, state-regulated pharmacies; not reviewed by FDA for safety, effectiveness or quality |
Pricing and promotional structure
Both providers advertise a $139 entry price for semaglutide, but the promo mechanics differ. Regenics lists semaglutide $139 for the first month and tirzepatide $189 first month, with renewals noted at higher monthly rates. He & She MD advertises similar headline prices as six-month introductory rates that renew at a higher six-month price. The comparison shows Regenics offers a single-month promotional entry, while He & She MD commits to a six-month intro term.
See He & She MD introductory plans
Clinician access and ongoing support
Regenics delivers nurse-practitioner-led telehealth care where licensed nurse practitioners review intake before any prescription and oversee GLP-1 prescribing. He & She MD emphasizes built-in support: every plan includes the He & She MD app with 1:1 clinician messaging, GLP-1 coaching, and progress tracking at no extra cost. If you prioritize bundled clinician messaging and coaching tools, He & She MD documents that these supports are included; Regenics focuses on clinician oversight without the same app-based coaching bundle.
Who oversees prescriptions
Regenics: licensed nurse practitioners review and oversee prescriptions. He & She MD: clinician access through 1:1 messaging within the app and a named Chief Medical Officer associated with the program.
Medication types, pharmacy compliance, and regulatory notes
Both sell compounded GLP-1 medications. Regenics lists compounded semaglutide and tirzepatide prepared by U.S. licensed compounding pharmacies and notes the pharmacy network is LegitScript certified. He & She MD offers semaglutide injections, oral semaglutide, and tirzepatide injections produced in USP-compliant, state-regulated pharmacies. Important regulatory language supplied for both: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Check Regenics medication details
Extras and best-fit use cases
Distinctive extras separate the two providers. Regenics highlights a Sermorelin peptide therapy add-on for recovery, energy, and muscle support as part of its offering. He & She MD bundles coaching, clinician messaging and progress tracking in an app at no additional cost. Regenics is telehealth only with no published in-person option; He & She MD does not require a separate membership fee and advertises free expedited shipping.
Final comparison and how to choose
Regenics vs He & She MD comes down to whether you prefer a lower-cost short-term entry and a peptide add-on or a program that includes coaching and clinician messaging as part of a longer promotional commitment. Both require clinician review and both use compounded medications not reviewed by the FDA.
Choose Regenics if you want a cash-pay entry with semaglutide $139 first month, tirzepatide $189 first month, nurse-practitioner oversight, and access to a Sermorelin peptide option.
Choose He & She MD if you want semaglutide or tirzepatide bundled with a coaching app, 1:1 clinician messaging and progress tracking included under six-month introductory rates.